| Literature DB >> 28877944 |
Einar Hovlid1, Jan C Frich2, Kieran Walshe3, Roy M Nilsen4, Hans Kristian Flaatten5, Geir Sverre Braut6, Jon Helgeland7, Inger Lise Teig8, Stig Harthug9.
Abstract
INTRODUCTION: Inspections are widely used in health care as a means to improve the health services delivered to patients. Despite their widespread use, there is little evidence of their effect. The mechanisms for how inspections can promote change are poorly understood. In this study, we use a national inspection campaign of sepsis detection and initial treatment in hospitals as case to: (1) Explore how inspections affect the involved organizations. (2) Evaluate what effect external inspections have on the process of delivering care to patients, measured by change in indicators reflecting how sepsis detection and treatment is carried out. (3) Evaluate whether external inspections affect patient outcomes, measured as change in the 30-day mortality rate and length of hospital stay. METHODS AND ANALYSIS: The intervention that we study is inspections of sepsis detection and treatment in hospitals. The intervention will be rolled out sequentially during 12 months to 24 hospitals. Our effect measures are change on indicators related to the detection and treatment of sepsis, the 30-day mortality rate and length of hospital stay. We collect data from patient records at baseline, before the inspections, and at 8 and 14 months after the inspections. We use logistic regression models and linear regression models to compare the various effect measurements between the intervention and control periods. All the models will include time as a covariate to adjust for potential secular changes in the effect measurements during the study period. We collect qualitative data before and after the inspections, and we will conduct a thematic content analysis to explore how inspections affect the involved organisations. ETHICS AND DISSEMINATION: The study has obtained ethical approval by the Regional Ethics Committee of Norway Nord and the Norwegian Data Protection Authority. It is registered at www.clinicaltrials.gov (Identifier: NCT02747121). Results will be reported in international peer-reviewed journals. TRIAL REGISTRATION: NCT02747121; Pre-results. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: effect; external inspection; regulation; sepsis; stepped wedge design
Mesh:
Year: 2017 PMID: 28877944 PMCID: PMC5589010 DOI: 10.1136/bmjopen-2017-016213
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Conceptual study framework.
Study design
| Year | 2015 | 2016 | 2017 | 2018 | ||||||||||||||||||||||||||||||
| Hospital/ month | S | O | N | D | J | F | M | A | M | J | J | A | S | O | N | D | J | F | M | A | M | J | J | A | S | O | N | D | J | F | M | A | M | J |
| 1 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 2 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 3 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 4 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 5 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 6 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 7 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 8 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 9 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 10 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 11 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 12 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 13 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 14 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 15 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 16 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 17 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 18 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 19 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 20 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 21 | P0 | FI | P1 | SV | P2 | FA | FI | P3 | FA | |||||||||||||||||||||||||
| 22 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 23 | P0 | P1 | SV | P2 | FA | P3 | FA | |||||||||||||||||||||||||||
| 24 | P0 | P1 | SV | P2 | FA | P3 | FA |
FA, follow-up audit; FI, focus group interviews; P0, baseline measurement; P1, measurement before site visit; P2, measurement 8 months after the site visit; P3, measurement 14 months after the site visit; SV, site visit.
Key elements of the intervention
| Time in months | Activity |
| 1 | Inspection team announces inspection and requests the hospital to submit information. |
| 2 | Inspection team reviews records of patients with sepsis and collect relevant data for the inspection criteria. Data are collected for two time periods, baseline (September 2015) and right before the site visit. |
| 3 | Two-day site visit at the hospital with interviews of key personnel. |
| 4–5 | The inspection team writes a preliminary report of their findings. The hospital can comment on the report. |
| 6 | The inspection team sends the final report to the hospital. |
| Continuously | The hospital plans and implements improvement measures. |
| 11 | Follow-up audit 8 months after the site visit. The inspection team reviews records of patients with sepsis and collect the same data as they did prior to the site visit. |
| 17 | Follow-up audit 14 months after the site visit. The inspection team reviews records of patients with sepsis and collect the same data as they did prior to the site visit. |
Figure 2Illustration of clusters and data collection.
Outline of regression models for the various process and outcome measurements
| Indicator | Dependent variable | Type | GEE model* |
| Process | Triage within 15 min | Binary | Logistic regression |
| Process | Timely assessment by physician | Binary | Logistic regression |
| Process | Vital signs evaluated within 30 min | Binary | Logistic regression |
| Process | Blood lactate measured within 30 min | Binary | Logistic regression |
| Process | Supplementing blood samples within 30 min | Binary | Logistic regression |
| Process | Blood culture taken before antibiotics | Binary | Logistic regression |
| Process | Adequate supplementing investigation within 24 hours | Binary | Logistic regression |
| Process | Antibiotic treatment within 1 hour | Binary | Logistic regression |
| Process | Intravenous fluid within 30 min | Binary | Logistic regression |
| Process | Oxygen therapy within 30 min | Binary | Logistic regression |
| Process | Adequate surveillance regime established | Binary | Logistic regression |
| Process | Adequate discharge from emergency room | Binary | Logistic regression |
| Outcome | 30 day mortality | Binary | Logistic regression |
| Outcome | Length of stay | Continuous† | Linear regression |
*Regression models with GEE.
†Transformed if skewed distribution.
GEE, generalised estimating methodology.